News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
68 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17656)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
BioMidwest
Neogen Announces 4-for-3 Stock Split
The stock split will be effected in the form of new common stock being issued on Dec. 29, 2017, to shareholders of record as of the close of business on Dec. 18, 2017.
December 8, 2017
·
2 min read
BioForest
Otoharmonics’ Levo Tinnitus System Shown to Have Better Outcomes Than Current Standard of Care
The Levo System has been cleared by the FDA for sales in the U.S. and is cleared for sale in Canada and Europe through CE Mark.
December 8, 2017
·
3 min read
Business
Guided Therapeutics Signs Preliminary License Agreement With Turkish Distribution Partner Based on Ministry of Health Support for the LuViva Advanced Cervical Scan
In return for the license and manufacturing rights for Cervical Guides in Turkey, GTHP will receive fees totaling $3,000,000 in 2018.
December 8, 2017
·
4 min read
Drug Development
Pfizer Shows Off Phase III Breast Cancer Data
The data will be presented today as an oral presentation at the 2017 San Antonio Breast Cancer Symposium.
December 8, 2017
·
10 min read
Genetown
Aphios Pharma Raising Equity Capital to Develop FDA-Approved, Cannabis-Based Drug for Opioid Addiction
The capital will be used to develop an FDA-approved, cannabis-based drug for treating opioid addiction, a highly unmet CNS disorder.
December 8, 2017
·
3 min read
Pharm Country
OraSure Technologies Announces 2018 Annual Meeting Date
Further details regarding the meeting will be provided at a later date.
December 8, 2017
·
1 min read
Drug Development
Photocure ASA: Landmark Blue Light Cystoscopy With Cysview Study is Published in the Journal of Urology
Out of the 304 patients in the study, 103 were referred to the Operating Room for suspicion of recurrent bladder cancer.
December 8, 2017
·
5 min read
Biotech Bay
Marrone Bio Innovations Announces the Availability of Amplitude Biofungicide for White Mold Control in the 2018 Growing Season
Amplitude is an effective new tool for controlling white molds in pulse, root and oilseed crops, as well as soil diseases like Rhizoctonia in large acre crops.
December 8, 2017
·
5 min read
BioForest
Adaptive Biotechnologies and Collaborators to Highlight Clinical Relevance of Measuring Residual Disease in Blood Cancers at ASH 2017
Data presented at ASH will demonstrate how Adaptive’s clonoSEQ Assay to measure MRD, the cancerous cells remaining in the body after treatment, can inform clinical care in patients with B and T cell lymphoid malignancies.
December 8, 2017
·
11 min read
Bio NC
Crown Bioscience Releases Scientific Posters Detailing Innovations in Preclinical Cancer Pharmacology
Crown Bioscience presented more than a dozen scientific posters describing innovations in the field of preclinical cancer research at AACR-NCI-EORTC 2017.
December 8, 2017
·
2 min read
Previous
3 of 7
Next